Use Your Location

Notes

We will only use the coordinates to detect the nearest postcodes to your reported location. This request is only initiated each time you click this button and your location is not tracked under any circumstances.

Please note that if your device does not contain a GPS locator service, such as a desktop computer, your device will be determined by your router and this may be configured by your ISP to not be near to your physical location for privacy purposes.

Advanced

Use Your Location

Notes

PARLIAMENTARY WRITTEN QUESTION
Dinutuximab Beta (13 June 2018)

Question Asked

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with representatives of Eusa Pharma on the availability of Dinutuximab Beta on the NHS.

Asked by:
Helen Hayes (Labour)

Answer

Departmental officials have had no such discussions. However, representatives of the National Institute for Health and Care Excellence are in regular contact with Eusa Pharma in the context of the ongoing technology appraisal of dinutuximab beta for the treatment of high risk neuroblastoma.

Answered by:
Steve Brine (Conservative)
21 June 2018

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.

Use Your Location

Use Your Location

PARLIAMENTARY WRITTEN QUESTION
Dinutuximab Beta (13 June 2018)

Question Asked

Answer

Information

Tools

Polices

StreetGuide

Follow us on Social Media

Use Your Location

Use Your Location

PARLIAMENTARY WRITTEN QUESTIONDinutuximab Beta (13 June 2018)

Question Asked .header-social-media-container { height:30px; width:80px; } .header-social-media-container.right { padding: 0px 0px 0px 8px; } .header-social-media-container.left { padding: 0px 8px 0px 0px; margin-bottom:30px; } .header-social-media-container img { height:30px; width:30px; }

Answer

PARLIAMENTARY WRITTEN QUESTION
Dinutuximab Beta (13 June 2018)

Question Asked